(Q40917009)

24 September 2017

High dose medroxyprogesterone acetate (MPA) treatment in metastatic carcinoma of the breast: a dose-response evaluation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354147

26 June 2022

High Dose Medroxyprogesterone Acetate (MPA) Treatment in Metastatic Carcinoma of the Breast: A Dose-Response Evaluation (English)

1 reference

https://api.crossref.org/works/10.1177/030089167806400204

5 April 2023

1 reference

medroxyprogesterone acetate

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354147

26 June 2022

developed country

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354147

26 June 2022

Mediterranean Countries

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354147

26 June 2022

Southern Europe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354147

26 June 2022

1 reference

https://api.crossref.org/works/10.1177/030089167806400204

5 April 2023

author name string

G. R. Cuna

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354147

26 June 2022

A. Calciati

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354147

26 June 2022

M. R. Strada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354147

26 June 2022

C. Bumma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354147

26 June 2022

L. Campio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354147

26 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=354147

26 June 2022

publication date

1 April 1978

1 reference

24 September 2017

30 April 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=354147

full work available at URL

26 June 2022

http://journals.sagepub.com/doi/pdf/10.1177/030089167806400204

1 reference

https://api.crossref.org/works/10.1177/030089167806400204

5 April 2023

1 reference

24 September 2017

64

1 reference

24 September 2017

2

1 reference

24 September 2017

143-149

1 reference

TESTOSTERONE PROPIONATE THERAPY IN BREAST CANCER

24 September 2017

7

1 reference

https://api.crossref.org/works/10.1177/030089167806400204

Alcohol infusion of the pituitary, high-dose medroxyprogesterone and their association as analgesics in advanced breast cancer (author's transl)

5 April 2023

12

1 reference

https://api.crossref.org/works/10.1177/030089167806400204

Treatment of breast cancer with medroxyprogesterone acetate

5 April 2023

13

1 reference

https://api.crossref.org/works/10.1177/030089167806400204

5 April 2023

14

2

1605

Pannuti F.

1974

1 reference

https://api.crossref.org/works/10.1177/030089167806400204

5 April 2023

16

18

129

Pannuti F.

1976

1 reference

https://api.crossref.org/works/10.1177/030089167806400204

5 April 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=354147

5 April 2023

1 reference